- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00207922
The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD
September 13, 2005 updated by: China Medical University Hospital
The purpose of this study is to see the correlation of polarization and the expresison of chemokine receptors of T help cells after allogeneic hematopoietic stem cell transplantation and clinical course graft-versus-host disease.
Study Overview
Status
Unknown
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patient received allogeneic stem cell transplantation at CMUH
- can be regularly followed at CMUH
Exclusion Criteria:
- patient who do not want to enter in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Su-Peng Yeh, MD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2003
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (Estimate)
September 21, 2005
Study Record Updates
Last Update Posted (Estimate)
September 21, 2005
Last Update Submitted That Met QC Criteria
September 13, 2005
Last Verified
December 1, 2003
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DMR92-IRB-135
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHematopoietic Stem Cell Transplantation | Graft-versus-host Disease
-
Sherif S. FaragCompletedHematopoietic Stem Cell Transplantation | Graft vs Host DiseaseUnited States
-
William R. Drobyski, MDCompletedHematopoietic Stem Cell TransplantationUnited States
-
Hospital Authority, Hong KongNovartis Pharmaceuticals; The Hong Kong Blood Cancer FoundationUnknownHematopoietic Stem Cell Transplantation | Graft vs Host DiseaseChina
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Shenzhen People... and other collaboratorsRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Acute-graft-versus-host DiseaseChina
-
Mehdi HamadaniCompletedAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio... and other collaboratorsCompletedLeukemia | Hematopoietic Stem Cell Transplantation | Graft Versus Host DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisAgence de La BiomédecineCompletedHematopoietic Stem Cell Transplantation | Graft Versus Host DiseaseFrance
-
Hospital Authority, Hong KongHoffmann-La RocheUnknownHematopoietic Stem Cell Transplantation | Graft vs Host DiseaseChina
-
University of FloridaAmerican Cancer Society, Inc.CompletedHematopoietic Stem Cell Transplantation | Graft vs Host Disease | Graft Versus Host Disease | Peripheral Blood Stem Cell TransplantationUnited States